COPD Assessment Test Can Predict Depression

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Hallym University Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Hallym University Medical Center
ClinicalTrials.gov Identifier:
NCT01727219
First received: November 12, 2012
Last updated: November 18, 2012
Last verified: February 2011
  Purpose

The frequency of depression in COPD patients are substantial and early detection and prevention of depression is critical.

Recently, COPD assessment test (CAT) was developed and validated to assess the impact of COPD on patients' quality of life.

In this prospective study, we will investigate the predictive utility of CAT for predicting depression in COPD patients.


Condition
Depression,
COPD

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: COPD Assessment Test Can Predict Depression

Further study details as provided by Hallym University Medical Center:

Primary Outcome Measures:
  • The predictive utility of the COPD assessment test (CAT) scores for predicting depression in COPD patients [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    The association of CAT with depression score


Estimated Enrollment: 600
Study Start Date: December 2012
Estimated Study Completion Date: May 2013
Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)
Detailed Description:

This study is aimed to investigate the association between the COPD Assessment Test (CAT) and depression in stable COPD patients. Stable COPD patients will be enrolled from the tertiary hospitals. All patients will undergo lung function tests. The Korean versions of the CAT (COPD assessment test) and Patient Health Questionnaire-9 (PHQ-9) will be used to assess COPD symptoms and depressive disorder, respectively.

We will compare the depresssion frequency among GOLD classifications of airway limitation and among the four CAT groups. And. we will also investigate which items of the CAT are the strongest indicators of depression.

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Stable COPD patients who visit outpatient departments.

Criteria

Inclusion Criteria:

  • COPD patients who aged > or = 40 years

Exclusion Criteria:

  • acute exacerbation within 3 months
  • bronchial asthma or an increase in FEV1 of more than 12% of the predicted value with the use of 400 µg of albuterol.
  • other lung diseases such as bronchiectasis, interstitial lung disease, and tuberculosis-destroyed lungs.
  • who denied to consent.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01727219

Contacts
Contact: Sunghoon Park, Dr. 82-31-380-3803 f2000tj@gmail.com

Locations
Korea, Republic of
Hallym University Sacred Heart Hospital, Department of Pulmonary, Critical Care Medicine Not yet recruiting
Anyang-, Gyeonggi-do, Korea, Republic of, 431-070
Contact: Sunghoon Park, MD    82-31-380-3803    f2000tj@gmail.com   
Contact: Sun Hyang Kim    82-31-380-1975    tjsgid625@naver.com   
Sponsors and Collaborators
Hallym University Medical Center
Investigators
Principal Investigator: KI-Suck Jung, Dr. Hallym University Medical Center
  More Information

No publications provided

Responsible Party: Hallym University Medical Center
ClinicalTrials.gov Identifier: NCT01727219     History of Changes
Other Study ID Numbers: 2011-I010
Study First Received: November 12, 2012
Last Updated: November 18, 2012
Health Authority: Korea: Ministry for Health, Welfare and Family Affairs

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on September 18, 2014